Literature DB >> 22952236

Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis.

Na Lian1, Tonghui Lin, Wenguang Liu, Weiguang Wang, Lingzhen Li, Stephanie Sun, Jeffry S Nyman, Xiangli Yang.   

Abstract

ATF4 is an osteoblast-enriched transcription factor of the leucine zipper family. We recently identified that vimentin, a leucine zipper-containing intermediate filament protein, suppresses ATF4-dependent osteocalcin (Ocn) transcription and osteoblast differentiation. Here we show that TGFβ inhibits ATF4-dependent activation of Ocn by up-regulation of vimentin expression. Osteoblasts lacking Atf4 (Atf4(-/-)) were less sensitive than wild-type (WT) cells to the inhibition by TGFβ on alkaline phosphatase activity, Ocn transcription and mineralization. Importantly, the anabolic effect of a monoclonal antibody neutralizing active TGFβ ligands on bone in WT mice was blunted in Atf4(-/-) mice. These data establish that ATF4 is required for TGFβ-related suppression of Ocn transcription and osteoblast differentiation in vitro and in vivo. Interestingly, TGFβ did not directly regulate the expression of ATF4; instead, it enhanced the expression of vimentin, a negative regulator of ATF4, at the post-transcriptional level. Accordingly, knockdown of endogenous vimentin in 2T3 osteoblasts abolished the inhibition of Ocn transcription by TGFβ, confirming an indirect mechanism by which TGFβ acts through vimentin to suppress ATF4-dependent Ocn activation. Furthermore, inhibition of PI3K/Akt/mTOR signaling, but not canonical Smad signaling, downstream of TGFβ, blocked TGFβ-induced synthesis of vimentin, and inhibited ATF4-dependent Ocn transcription in osteoblasts. Thus, our study identifies that TGFβ stimulates vimentin production via PI3K-Akt-mTOR signaling, which leads to suppression of ATF4-dependent Ocn transcription and osteoblast differentiation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22952236      PMCID: PMC3476265          DOI: 10.1074/jbc.M112.372458

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome.

Authors:  Xiangli Yang; Koichi Matsuda; Peter Bialek; Sylvie Jacquot; Howard C Masuoka; Thorsten Schinke; Lingzhen Li; Stefano Brancorsini; Paolo Sassone-Corsi; Tim M Townes; Andre Hanauer; Gerard Karsenty
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

Review 2.  Molecular and cellular biology of intermediate filaments.

Authors:  P M Steinert; D R Roop
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

3.  Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3.

Authors:  Jong Seok Kang; Tamara Alliston; Rachel Delston; Rik Derynck
Journal:  EMBO J       Date:  2005-06-30       Impact factor: 11.598

4.  Intermediate filament proteins in the developing chick spinal cord.

Authors:  S J Tapscott; G S Bennett; Y Toyama; F Kleinbart; H Holtzer
Journal:  Dev Biol       Date:  1981-08       Impact factor: 3.582

5.  Characterization and regulation in the expression of a gene coding for the intermediate filament protein desmin.

Authors:  Y G Capetanaki; J Ngai; E Lazarides
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

6.  Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification.

Authors:  J R Dasch; D R Pace; W Waegell; D Inenaga; L Ellingsworth
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

Review 7.  Osteocalcin: the vitamin K-dependent Ca2+-binding protein of bone matrix.

Authors:  P V Hauschka
Journal:  Haemostasis       Date:  1986

8.  SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.

Authors:  Stacey DaCosta Byfield; Christopher Major; Nicholas J Laping; Anita B Roberts
Journal:  Mol Pharmacol       Date:  2004-03       Impact factor: 4.436

9.  Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro.

Authors:  P G Robey; M F Young; K C Flanders; N S Roche; P Kondaiah; A H Reddi; J D Termine; M B Sporn; A B Roberts
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

10.  Osteoblasts isolated from mouse calvaria initiate matrix mineralization in culture.

Authors:  B Ecarot-Charrier; F H Glorieux; M van der Rest; G Pereira
Journal:  J Cell Biol       Date:  1983-03       Impact factor: 10.539

View more
  28 in total

1.  Transcriptional profile of HIV-induced nuclear translocation of amyloid β in brain endothelial cells.

Authors:  Ibolya E András; Evadnie Rampersaud; Sung Yong Eum; Michal Toborek
Journal:  Arch Med Res       Date:  2014-11-13       Impact factor: 2.235

2.  The cytoskeleton meets the skeleton. Focus on "Deficiency of the intermediate filament synemin reduces bone mass in vivo".

Authors:  Omar Skalli
Journal:  Am J Physiol Cell Physiol       Date:  2016-10-26       Impact factor: 4.249

3.  The loss of activating transcription factor 4 (ATF4) reduces bone toughness and fracture toughness.

Authors:  Alexander J Makowski; Sasidhar Uppuganti; Sandra A Wadeer; Jack M Whitehead; Barbara J Rowland; Mathilde Granke; Anita Mahadevan-Jansen; Xiangli Yang; Jeffry S Nyman
Journal:  Bone       Date:  2014-02-07       Impact factor: 4.398

4.  The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent.

Authors:  S E Tahaei; G Couasnay; Y Ma; N Paria; J Gu; B F Lemoine; X Wang; J J Rios; F Elefteriou
Journal:  Bone       Date:  2017-10-12       Impact factor: 4.398

5.  Down-regulated expression of vimentin induced by mechanical stress in fibroblasts derived from patients with ossification of the posterior longitudinal ligament.

Authors:  Wei Zhang; Peng Wei; Yu Chen; Lili Yang; Cheng Jiang; Ping Jiang; Deyu Chen
Journal:  Eur Spine J       Date:  2014-06-08       Impact factor: 3.134

6.  Hop2 Interacts with ATF4 to Promote Osteoblast Differentiation.

Authors:  Yang Zhang; Tonghui Lin; Na Lian; Huan Tao; Cong Li; Lingzhen Li; Xiangli Yang
Journal:  J Bone Miner Res       Date:  2019-11-04       Impact factor: 6.741

7.  Vimentin is important in the neural differentiation of PC12 cells promoted by sialylation.

Authors:  Li Hui Wu; Xiao Ting Shao; Jun Xia Guo; Hui Sun; Qi Chen; Jing Pan; Qian Qian Cai; Yi Wei Dong; Zhong Yi Chen; Xiao Mei Yan; Min Peng; Nanbert Zhong; Xing Zhong Wu
Journal:  Glycoconj J       Date:  2016-10-10       Impact factor: 2.916

8.  Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro.

Authors:  Samir M Abdelmagid; Joyce Y Belcher; Fouad M Moussa; Suzanne L Lababidi; Gregory R Sondag; Kimberly M Novak; Afif S Sanyurah; Nagat A Frara; Roshanak Razmpour; Fabiola E Del Carpio-Cano; Fayez F Safadi
Journal:  Am J Pathol       Date:  2014-01-23       Impact factor: 4.307

9.  Immunology of Gut-Bone Signaling.

Authors:  Fraser L Collins; Jonathan D Schepper; Naiomy Deliz Rios-Arce; Michael D Steury; Ho Jun Kang; Heather Mallin; Daniel Schoenherr; Glen Camfield; Saima Chishti; Laura R McCabe; Narayanan Parameswaran
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

10.  Physical vapour deposition of zirconia on titanium: fabrication, characterization and interaction with human osteoblast cells.

Authors:  Milena R Kaluđerović; Stephan Mändl; Hannes Kohlweyer; Hans-Ludwig Graf
Journal:  J Mater Sci Mater Med       Date:  2015-10-27       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.